Press releases
- dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty
- dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform
- Methane-reducing feed ingredient Bovaer® ready for US market launch
- dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024
- Share repurchase program to cover share plans completed
- dsm-firmenich Q1 2024 trading update
- Progress on share repurchase program to cover share plans
- dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
- dsm-firmenich announces repurchase of 1.5m shares to cover share plans
- Ad Hoc Press Release - Regulated Information
More ▼
Key statistics
On Friday, DSM-Firmenich AG (ZX6:FRA) closed at 99.96, -8.63% below its 52-week high of 109.40, set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 101.15 |
---|---|
High | 101.15 |
Low | 99.96 |
Bid | 99.62 |
Offer | 102.55 |
Previous close | 101.40 |
Average volume | 82.33 |
---|---|
Shares outstanding | 265.68m |
Free float | 66.89m |
P/E (TTM) | -- |
Market cap | 26.82bn EUR |
EPS (TTM) | -- |
Annual div (ADY) | 2.50 EUR |
---|---|
Annual div yield (ADY) | 2.47% |
Div ex-date | May 09 2024 |
Div pay-date | May 16 2024 |
Data delayed at least 15 minutes, as of Jun 07 2024 14:29 BST.
More ▼